10.46243/jst.2020.v5.i5.pp01-09 registered
Review on Types of Three Components Reactions
Resolves to https://www.jst.org.in/index.php/pub/article/view/250
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i5.pp01-09
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 9325ca016b37749e…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Review on Types of Three Components Reactions (PrincipalTitle · en)
Published 2020-08-07
Part of Journal of Science & Technology · ISSN 2456-5660 · issue Volume 5 · pages 01–09
Agents
- Dr. NaghamMahmoodAljamali (author) · Professor, Sub-Department of Basic Science, Faculty of Nursing, KufaUniv, Iraq
- Dr. AmalSaadoon Majeed (author) · Professor, Sub-Department of Basic Science, Faculty of Nursing, KufaUniv, Iraq
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2020.v5.i5.pp01-09
Abstract · en
This review described the three-component chemical reactions, their types, how they got there, and their importance in preparing compounds that have biological and pharmaceutical significance and in other magazines of chemistry. Among them are the enamin-mannich reactions, the formazane reactions, the sulfazane, and some annular closure reactions.Three-component interaction is included in the preparation of the pharmaceutical compounds, as they need the shortest steps and the fastest results, so such interactions are used in the preparation of many drugs and the simplest examples are tramadol and some anesthetics used in surgical processes
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2020.v5.i5.pp01-09 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Review on Types of Three Components Reactions (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Dr. NaghamMahmoodAljamali author: Dr. AmalSaadoon Majeed publisher: Longman Publishers published: 2020-08-07 part of: Journal of Science & Technology · ISSN 2456-5660 · no. Volume 5 · pp. 01–09 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2020-08-07 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
Recommended for a journal article and not in this record: the volume number.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 70 references; 45 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 2 | ref2 Almasirad A, Tabatabai SA, Faizi M, Kebriaeezadeh A, Mehrabi N, Dalvandi A, Shafiee A. Synthesis and anticonvulsant activity of new 2 substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3… | 10.1016/j.bmcl.2004.09.072 | not held here |
| 3 | ref3 Al-Soud YA, Al-Dweri MN, Al-Masoudi NA. Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Farmaco. 2004;59:775–783. doi: 10.1016/j.farmac.2004.05.0… | 10.1016/j.farmac.2004.05.006 | not held here |
| 4 | ref4 Mieaad M, NaghamMahmoodAljamali, WassanAlaShubber., Sabreen Ali Abdalrahman."New Azomethine-Azo Heterocyclic Ligands Via Cyclization of Ester".,Research Journal of Pharmacy and Te… | 10.5958/0974-360x.2018.00472.9 | not held here |
| 5 | ref5 Bailey EM, Krakovsky DJ, Rybak M. The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy. 1990;10:146– | 10.1002/j.1875-9114.1990.tb02561.x | not held here |
| 6 | ref6 Bourgeois I, Pestel-Caron M, Lemeland JF, Pons JL, Caron F. Tolerance to the glycopeptidesvancomycin and teicoplanin in coagulase negative Staphylococci. Antimicrob Agents Chemoth… | 10.1128/aac.00719-06 | not held here |
| 7 | ref7 NaghamMahmoodAljamali.; Intisar O A. "Synthesis of Sulfur Heterocyclic Compounds and Study of Expecte d Biological Activity",Research J. Pharm. and Tech., 2015, 8,9,1225-1242, DOI… | 10.5958/0974-360x.2015.00224.3 | not held here |
| 8 | ref8 Clemons M, Coleman RE, Verma S. Cancer Treat Rev. 2004;30:325–332. doi: 10.1016/j.ctrv.2004.03.004. [PubMed] [ CrossRef] [Google Scholar] | 10.1016/j.ctrv.2004.03.004 | not held here |
| 10 | ref10 AfaeqgaberKadem, Ahmed Adnan Abdul Hussein, NaghamMahmoodAljamali,Ahmed A A H, Afaq J K. (2020)., Invention of Imidazole &Thiazole-Sulfazane Ligands (Synthesis, Spectral Investiga… | 10.31838/ijpr/2020.12.02.0151 | not held here |
| 15 | ref15 Alea JK, JelalHasen Mohamed, NaghamMahmoodAljamali., Thiazole Amide Derivatives (Synthesis, Spectral Investigation, Chemical Properties, Antifungal Assay)., NeuroQuantology, 2020,… | 10.14704/nq.2020.18.1.nq20102 | not held here |
| 16 | ref16 Metwally N.H. A simple green synthesis of (Z) -5-arylmethylene-4-thioxothiazolidines and thiopyrano[2,3-d]thiazolidine-2-thiones in PEG-400 under catalyst-free conditions. J. Sulf… | 10.1080/17415993.2014.933341 | not held here |
| 17 | ref17 Lozynskyi A., Zimenkovsky B., Lesyk R. Synthesis and Anticancer Activity of New Thiopyrano[2,3-d]thiazoles Based on Cinnamic Acid Amides. Sci. Pharm. 2014;82:723–733. doi: 10.3797… | 10.3797/scipharm.1408-05 | not held here |
| 18 | ref18 Lozynskyi A., Zasidko V., Atamanyuk D., Kaminskyy D., Derkach H., Karpenko O., Ogurtsov V., Kutsyk R., Lesyk R. Synthesis, an tioxidant and antimicrobial activities of novel thiop… | 10.1007/s11030-017-9737-8 | not held here |
| 19 | ref19 Lozynskyi A., Zimenkovsky B., Nektegayev I., Lesyk R. Arylidene pyruvic acids motif in the synthesis of new thiopyrano[2,3-d]thiazoles as potential biologically active compounds. … | 10.1515/hc-2014-0204 | not held here |
| 21 | ref21 AseelMahmoodJawad, NaghamMahmoodAljamali, SaherMahmoodJwad, Aseel M J, Saher M J., Development and Preparation of ciprofloxacin Drug Derivatives for Treatment of Microbial Contami… | 10.37506/ijfmt.v14i2.3067 | not held here |
| 23 | ref23 Demirbas A, Sahin D, Demirbas N, Karaoglu SA. Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities. Eur… | 10.1016/j.ejmech.2008.12.005 | not held here |
| 26 | ref26 NaghamMahmoodAljamali, Imad Kareem AlwanAlsabri., Development of Trimethoprim Drug and Innovation of Sulfazane-Trimethoprim Derivatives as Anticancer Agents., Biomedical & Pharmac… | 10.13005/bpj/1925 | not held here |
| 28 | ref28 Dogan HN, Duran A, Rollas S, Sener G, Uysal MK, Gülen D. Synthesis of new 2,5-disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activ… | 10.1016/s0968-0896(02)00143-8 | not held here |
| 30 | ref30 Metwally N.H. Synthesis of some new fused thiopyrano[2,3-d]thiazoles and their derivatives. J. Sulfur Chem. 2007;28:275–284. d oi: 10.1080/17415990701299468 | 10.1080/17415990701299468 | not held here |
| 31 | ref31 NaghamMahmoodAljamali, (2015). Review in Azo Compounds and its Biological Activity. Biochem Anal Biochem,4, 169., doi:10.4172/2161- 1009.1000169 | 10.4172/2161-1009.1000169 | not held here |
| 33 | ref33 Duran A, Dogan HN, Rollas S. Synthesis and preliminary anticancer activity of new 1,4-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H- 1,2,4-triazoline-5-thiones. Farmaco. 2002;… | 10.1016/s0014-827x(02)01248-x | not held here |
| 34 | ref34 El Shehry MF, Abu-Hashem AA, El-Telbani EM. Synthesis of 3 -((2,4-dichlorophenoxy)methyl)-1,2,4-triazolo(thiadiazoles and thiadiazines) as anti-inflammatory and molluscicidal agen… | 10.1016/j.ejmech.2010.01.030 | not held here |
| 35 | ref35 Gadad AK, Noolvi MN, Karpoormath RV. Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo-[2,1-b]-1,3,4-thiadiazole derivative… | 10.1016/j.bmc.2004.07.060 | not held here |
| 36 | ref36 Gülerman NN, Doğan HN, Rollas S, Johansson C, Çelik C. Synthesis and structure elucidation of some new thioether derivatives of 1,2,4 triazoline-3-thiones and their antimicrobial … | 10.1016/s0014-827x(01)01167-3 | not held here |
| 38 | ref38 NaghamMahmoodAljamali., 2015. Synthesis and Chemical Identification of Macro Compounds of (Thiazol and Imidazol)".,Research J. Pharm. and Tech, 8,1, 78-84., DOI: 10.5958/0974-360X… | 10.5958/0974-360x.2015.00016.5 | not held here |
| 39 | ref39 Zelisko N., Karpenko O., Muzychenko V., Gzella A., Grellier P., Lesyk R. trans-Aconitic acid-based hetero-Diels-Alder reaction in the synthesis of thiopyrano[2,3-d][1,3]thiazole d… | 10.1016/j.tetlet.2017.03.062 | not held here |
| 40 | ref40 Zelisko N.I., Finiuk N.S., Shvets V.M., Medvid Y.O., Stoika R.S., Lesyk R.B. Screening of spi ro-substituted thiopyrano[2,3-d]thiazoles for their cytotoxic action on tumor cells. … | 10.7124/bc.00095a | not held here |
| 41 | ref41 Mestaf M, NawfelMuhammedBaqerMuhsin., NeuroQuantology, 2019.,17 (11), 11-16., 10.14704/nq.2019. 17.11.NQ19108 | 10.14704/nq.2019.17.11.nq19108 | not held here |
| 43 | ref43 Harish K, Sadique AJ, Suroor AK, Mohammad A. 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of b… | 10.1016/j.ejmech.2008.01.039 | not held here |
| 44 | ref44 AseelMahmoodJawad, NaghamMahmoodAljamali, Aseel M J.,"Innovation, Preparation of Cephalexin Drug Derivatives and Studying of (Toxicity & Resistance of Infection)"., International … | 10.37200/ijpr/v24i4/pr201489 | not held here |
| 48 | ref48 Klimešová V, Zahajská L, Waisser K, Kaustová J, Möllmann U. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives. Farmaco. 2004;59:279–288. doi:… | 10.1016/j.farmac.2004.01.006 | not held here |
| 49 | ref49 Kumar D, Kumar NM, Chang K-H, Shah K. Synthesis and anticancer activity of 5 -(3-indolyl)-1,3,4-thiadiazoles. Eur J Med Chem. 2010;45:4664–4668. doi: 10.1016/j.ejmech.2010.07.023 | 10.1016/j.ejmech.2010.07.023 | not held here |
| 52 | ref52 Liesen AP, De Aquino TM, Carvalho CS, Lima VT, De Araújo JM, De Lima JG, De Faria AR, De Melo EJT, Alves AJ, Alves EW, Alves AQ, Góes AJS. Synthesis and evaluation of anti-Toxopla… | 10.1016/j.ejmech.2010.05.017 | not held here |
| 53 | ref53 McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR, Rinaldi MG. Antimicrob Agents Chemother. 1997;41:1832–1834 | 10.1128/aac.41.8.1832 | not held here |
| 55 | ref55 Padmavathi V, Sudhakar Reddy G, Padmaja A, Kondaiah P, Ali-Shazia Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. E… | 10.1016/j.ejmech.2008.10.012 | not held here |
| 57 | ref57 Ramasubbu N, Parthasarathy R. Short S…O contacts: structure of 2,5-bis(p-methoxyphenylhydroxymethyl)thiophene. ActaCrystallogr C. 1989;45:457–460. doi: 10.1107/S0108270188010728 | 10.1107/s0108270188010728 | not held here |
| 59 | ref59 Sheldrick GM. A short history of SHELX. ActaCrystallogr A. 2008;64:112–122. doi: 10.1107/S0108767307043930 | 10.1107/s0108767307043930 | not held here |
| 60 | ref60 Shiradkar MR, Murahari KK, Gangadasu HR, Suresh T, KalyanChA, Panchal D, Kaur R, Burange P, Ghogare J, Mokale V, Raut M. Synthesis of new S-derivatives of clubbed triazolylthiazol… | 10.1016/j.bmc.2007.04.003 | not held here |
| 61 | ref61 Siwek A, Paneth P. Computational studies of the cyclization of thiosemicarbazides. J Phys Org Chem. 2007;20:463–468. doi: 10.1002/poc.1179 | 10.1002/poc.1179 | not held here |
| 62 | ref62 Siwek A, Wujec M, Dobosz M, Wawrzycka-Gorczyca I. Study of direction of cyclization of 1-azolil-4-aryl/alkyl-thiosemicarbazides. Heteroat Chem. 2010;21(7):521–532. doi: 10.1002/hc… | 10.1002/hc.20643 | not held here |
| 64 | ref64 Ulusoy N, Gürsoy A, Ötük G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco. 2001;56:947–952. doi: 10.1016/S0014-827X(01)011… | 10.1016/s0014-827x(01)01128-4 | not held here |
| 65 | ref65 Wei Q-L, Zhang S-S, Gao J, Li W-H, Xu L-Z, Yu Z-G. Synthesis and QSAR studies of novel triazole compounds containing thioamide as potential antifungal agents. Bioorg Med Chem. 200… | 10.1016/j.bmc.2006.06.065 | not held here |
| 66 | ref66 White EL, Suling WJ, Ross LJ, Seitz LE, Reynolds RC. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J AntimicrobChemother. 2002;50:111–114. doi: 10… | 10.1093/jac/dkf075 | not held here |
| 68 | ref68 Wujec M, Paneth P. Mechanism of 4-methyl-1,2,4-triazol-3-thiole reaction with formaldehyde. A DFT study. J Phys Org Chem. 2007;20:1043–1049. doi: 10.1002/poc.1250 | 10.1002/poc.1250 | not held here |
| 69 | ref69 Polovkovych S.V., Karkhut A.I., Marintsova N.G., Lesyk R.B., Zimenkovsky B.S., Novikov V.P. Synthesis of New Schiff Bases and Polycyclic Fused Thiopyranothiazoles Containing 4,6-D… | 10.1002/jhet.890 | not held here |
| 70 | ref70 Metwally N.H. A convenient synthesis o f some new 5-substituted-4-thioxo-thiazolidines and fused thiopyrano[2,3-d]thiazole derivatives. Phosphorus Sulfur Silicon Relat. Elem. 2008… | 10.1080/10426500701849105 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 242 fields set · sha256 131592fc1fd0… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 21 Sep 2026, 07:31 | Metadata completed abstract (92 words) · licence | ● waiting for Crossref's answer | 3a7e3ca48327… |
| 21 Sep 2026, 07:53 | Read back: Crossref's record shows it | ● confirmed | ed4bbc1b29b5… |
2 entries · the last fingerprint ed4bbc1b29b53f58be9375bc49178bafaf59d838e8733b38e18984610ec60114 · the history as JSON, each entry with the fingerprint before it, to check them yourself.



